India – Lacerta Bio

No incentive to Indian pharma to innovate

Post author:Carlos
Post published:April 5, 2013
Post category:Drug Development Emerging Markets
Post comments:0 Comments

Very interesting point made by Ranjit Shahani from Novartis India: The immense talents in India's pharmaceutical companies should be focused on R&D of medicines that will help the people…

Sandoz closes generic development center in India

Post author:Carlos
Post published:December 5, 2012
Post category:CRO Downsizing Emerging Markets
Post comments:0 Comments

Last week, Sandoz announced they are closing a number of generic product development centers around the world, including the Sandoz Development Centre near Mumbai. A few items in this report…

Get in touch